Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v12-EN
Language English English
Date Updated 2022-03-26 2022-03-26
Drug Identification Number 00786306 00786306
Brand name POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR
Common or Proper name Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients POTASSIUM CHLORIDE SODIUM CHLORIDE DEXTROSE POTASSIUM CHLORIDE SODIUM CHLORIDE DEXTROSE
Strength(s) 300MG 900MG 5G 300MG 900MG 5G
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 14 bags / case (Product Code: 2B2454X) 14 bags / case (Product Code: 2B2454X)
ATC code B05BB B05BB
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-02-25 2022-02-25
Actual start date 2022-02-25 2022-02-25
Estimated end date 2022-03-25 2022-03-25
Actual end date 2022-03-25 2022-03-25
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments We have identified four alternative Baxter codes for your consideration if aligned to clinical practice: JB1674, JB1434, JB1264, and JB1984 We have identified four alternative Baxter codes for your consideration if aligned to clinical practice: JB1674, JB1434, JB1264, and JB1984
Health Canada comments